With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknown protection.

Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says ...

The Ebola outbreak in central Africa sparked by the rare Bundibugyo strain, for which no vaccines or therapies are licensed, ...

A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other similar research efforts are also in the very early stages.

The team are working on testing the ChAdOx1 BDBV vaccine, a type of viral-vector vaccine that has been previously used in the ...

Doctors battling a rare strain of Ebola in central Africa will probably need to wait many months for a vaccine to be ready ...

Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic ...

International experts are working on the vaccine as more people isolate after the cruise ship outbreak.

Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.

Lyme disease is the most common tick-borne infectious disease in the United States. There is no vaccine to protect against it in humans. Biopharmaceutical company Pfizer and Valne ...